Related Experiment Video
Updated: Mar 17, 2026

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
Published on: January 26, 2019
Screening for Host Factors Directly Interacting with RSV Protein: Microfluidics
Sarit Kipper1, Dorit Avrahami1, Monika Bajorek2
1Nanotechnology Institute, Mina and Everard Goodman Faculty of Life Sciences, Bar Ilan University, Ramat Gan, Israel.
This study introduces a microfluidics platform to find new host cell binding partners for respiratory syncytial virus (RSV) matrix (M) protein. The new method identifies host interactors, aiding antiviral strategy development.
Area of Science:
- Virology
- Biotechnology
- Microfluidics
Background:
- Viral proteins, like respiratory syncytial virus (RSV) matrix (M) protein, are multifunctional, leading to complex host interactions.
- Conventional high-throughput methods face challenges in fully characterizing these intricate viral-host protein-protein interactions.
- Understanding the virus-host interactome is crucial for developing effective antiviral strategies.
Purpose of the Study:
- To develop and utilize a high-throughput microfluidics platform for identifying novel host cell binding partners of the RSV M protein.
- To overcome limitations of traditional methods in studying complex viral-host protein interactions.
- To uncover new host interactors of RSV M protein involved in various cellular pathways.
Main Methods:
- A microfluidics platform featuring thousands of micro-mechanical valve-controlled reaction chambers was designed.
- The platform was integrated with a custom-made gene library printed on a microarray.
- On-chip transcription and translation generated a protein array for binding assays with RSV M protein.
Main Results:
- The microfluidics platform successfully identified novel host interactors of the RSV M protein.
- These newly identified interactors are involved in diverse cellular pathways.
- The study demonstrated the efficacy of microfluidics in interrogating protein-protein interactions.
Conclusions:
- The developed microfluidics platform is effective for high-throughput identification of viral protein interactors.
- The identified host interactors provide novel insights into the RSV-host interactome.
- These findings have significant implications for the development of future antiviral therapies targeting viral-host interactions.
More Related Videos
08:07Author Spotlight: Advancing Antiviral Strategies Through Novel Immunocapture and Mass Spectrometry Techniques
Published on: January 12, 2024
09:01An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013